Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

34,694 people played the daily Crossword recently. Can you solve it faster than others?34,694 people played the daily Crossword recently. Can you solve it faster than others?

Spinal cord stimulators have become a cornerstone for ... Boston Scientific, Abbott, LivaNova, NEVRO, and BrainsWay. The Infinity DBS system from Abbott integrates directional leads with 8 contact ...

Spinal cord stimulators ... magnetic stimulators have also expanded into outpatient clinics, and a high-end model from Magstim Company cools its coils in less than 7 minutes to ensure back-to-back ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

but it was the wellness tech he wears every day that really caught my eye. The Pulsetto, which costs £240, looks like a pair of sleek headphones but it’s actually a vagus nerve stimulator that you ...

aDivision of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada bDivision of Neurosurgery, Toronto Western Hospital, University Health ...